| Financial Year |
March 31 2023 |
| Monetary Funds |
178,864,884.36 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
31,948,799.54 |
| Accounts Receivable |
198,838,467.14 |
| Advances to Suppliers |
9,992,711.14 |
| Other Receivables |
7,584,344.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
341,141,715.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,320,609.57 |
| Total Current Assets |
784,691,531.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
977,317,758.81 |
| Under-construction Projects |
41,645,106.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
47,040,977.58 |
| R&D expenses |
9,095,589.52 |
| Goodwill |
4,133,969.62 |
| Long-Term Deferred and Prepaid Expenses |
14,448,150.81 |
| Deferred Income Tax Assets |
63,411,723.76 |
| Other Non-Current Assets |
9,263,394.95 |
| Sub-Total of Non-Current Assets |
1,168,980,067.78 |
| Total Assets |
1,953,671,599.60 |
| Short-Term Loans |
267,021,602.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
105,000,000.00 |
| Accounts Payable |
46,223,746.28 |
| Accounts Received In Advance |
330,290.39 |
| Employee Compensation Payable |
7,813,734.39 |
| Taxes Payable |
6,668,705.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
30,212,612.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
173,004,222.88 |
| Other Current Liabilities |
1,692,482.49 |
| Sub-Total of Current Liabilities |
637,967,397.05 |
| Long-term Loans |
206,458,294.04 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
15,007,456.60 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
32,896,376.30 |
| Other Non-Current Liabilities |
10,971,350.18 |
| Sub-Total of Non-Current Liabilities |
306,116,714.66 |
| Total Liabilities |
944,084,111.71 |
| Paid-In Capital(Or Share Stock) |
280,804,251.00 |
| Capital Surplus |
699,052,147.04 |
| Surplus Reserve |
40,337,631.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-10,606,541.68 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,009,587,487.89 |
| Owner's Equity（Stockholder's Equity） |
1,009,587,487.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,953,671,599.60 |
